Bank of America
PROF

Bank of America’s Profound Medical PROF Stock Holding History

Bank of America’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-96
Closed -$756 – 6597
2025
Q4 		$756 Sell
96
-200,064
-100% -$1.29M ﹤0.01% 6501
2025
Q3 		$979K Buy
200,160
+24,974
+14% +$127K ﹤0.01% 5336
2025
Q2 		$1.03M Sell
175,186
-27,404
-14% -$145K ﹤0.01% 5281
2025
Q1 		$1.18M Hold
202,590
– – ﹤0.01% 5106
2024
Q4 		$1.52M Sell
202,590
-500
-0.2% -$3.84K ﹤0.01% 4678
2024
Q3 		$1.62M Sell
203,090
-200
-0.1% -$1.81K ﹤0.01% 4721
2024
Q2 		$1.71M Sell
203,290
-700
-0.3% -$5.64K ﹤0.01% 4548
2024
Q1 		$1.74M Sell
203,990
-4,253
-2% -$35.5K ﹤0.01% 4534
2023
Q4 		$1.77M Buy
208,243
+25,830
+14% +$245K ﹤0.01% 4532
2023
Q3 		$1.86M Buy
182,413
+4,071
+2% +$42.2K ﹤0.01% 4318
2023
Q2 		$2.32M Buy
178,342
+802
+0.5% +$9.95K ﹤0.01% 4093
2023
Q1 		$1.65M Sell
177,540
-1,833
-1% -$21.2K ﹤0.01% 4515
2022
Q4 		$1.95M Buy
179,373
+3,773
+2% +$20.6K ﹤0.01% 4280
2022
Q3 		$710K Buy
175,600
+98,100
+127% +$662K ﹤0.01% 5123
2022
Q2 		$565K Sell
77,500
-878
-1% -$6.94K ﹤0.01% 5346
2022
Q1 		$706K Buy
78,378
+3,192
+4% +$30.7K ﹤0.01% 5546
2021
Q4 		$844K Sell
75,186
-12,042
-14% -$150K ﹤0.01% 5443
2021
Q3 		$1.28M Buy
87,228
+37,042
+74% +$564K ﹤0.01% 4838
2021
Q2 		$821K Sell
50,186
-11,085
-18% -$206K ﹤0.01% 5053
2021
Q1 		$1.23M Buy
61,271
+8,274
+16% +$198K ﹤0.01% 4658
2020
Q4 		$1.09M Sell
52,997
-12,407
-19% -$228K ﹤0.01% 4424
2020
Q3 		$1.15M Buy
65,404
+25,118
+62% +$399K ﹤0.01% 4107
2020
Q2 		$683K Buy
40,286
+5,900
+17% +$74.5K ﹤0.01% 4393
2020
Q1 		$335K Buy
34,386
+29,163
+558% +$378K ﹤0.01% 4789
2019
Q4 		$57K Buy
+5,223
New +$48.1K ﹤0.01% 6222

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Bank of America's PROF Position: Q1 2026 in Review

Bank of America sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 96 shares — an estimated $756 sold.

Bank of America first reported a position in PROF in Q4 2019 and held it in 25 quarters. The position peaked at $2.32M in Q2 2023. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Bank of America reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 96 Profound Medical shares in Q1 2026, an estimated $756.
  • Bank of America first reported a position in Profound Medical in Q4 2019 and held it in 25 quarters.
  • Bank of America's Profound Medical position peaked at $2.32M in Q2 2023.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.